Ligresti A - Search Results

1

Cannabinomimetic lipid from a marine cyanobacterium.

Gutiérrez M, Pereira AR, Debonsi HM, Ligresti A, Di Marzo V, Gerwick WH. Gutiérrez M, et al. Among authors: ligresti a. J Nat Prod. 2011 Oct 28;74(10):2313-7. doi: 10.1021/np200610t. Epub 2011 Oct 14. J Nat Prod. 2011. PMID: 21999614 Free PMC article.

2

Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs.

Graziano G, Stefanachi A, Contino M, Prieto-Díaz R, Ligresti A, Kumar P, Scilimati A, Sotelo E, Leonetti F. Graziano G, et al. Among authors: ligresti a. Int J Mol Sci. 2023 Apr 1;24(7):6581. doi: 10.3390/ijms24076581. Int J Mol Sci. 2023. PMID: 37047554 Free PMC article. Review.

3

Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors.

Appendino G, Ligresti A, Minassi A, Daddario N, Bisogno T, Di Marzo V. Appendino G, et al. Among authors: ligresti a. Bioorg Med Chem Lett. 2003 Jan 6;13(1):43-6. doi: 10.1016/s0960-894x(02)00839-9. Bioorg Med Chem Lett. 2003. PMID: 12467613

4

Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.

De Petrocellis L, Bisogno T, Ligresti A, Bifulco M, Melck D, Di Marzo V. De Petrocellis L, et al. Among authors: ligresti a. Fundam Clin Pharmacol. 2002 Aug;16(4):297-302. doi: 10.1046/j.1472-8206.2002.00094.x. Fundam Clin Pharmacol. 2002. PMID: 12570018

5

Novel selective and metabolically stable inhibitors of anandamide cellular uptake.

Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V. Ortar G, et al. Among authors: ligresti a. Biochem Pharmacol. 2003 May 1;65(9):1473-81. doi: 10.1016/s0006-2952(03)00109-6. Biochem Pharmacol. 2003. PMID: 12732359

6

Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena.

Han B, McPhail KL, Ligresti A, Di Marzo V, Gerwick WH. Han B, et al. Among authors: ligresti a. J Nat Prod. 2003 Oct;66(10):1364-8. doi: 10.1021/np030242n. J Nat Prod. 2003. PMID: 14575438

7

A new strategy to block tumor growth by inhibiting endocannabinoid inactivation.

Bifulco M, Laezza C, Valenti M, Ligresti A, Portella G, DI Marzo V. Bifulco M, et al. Among authors: ligresti a. FASEB J. 2004 Oct;18(13):1606-8. doi: 10.1096/fj.04-1754fje. Epub 2004 Aug 2. FASEB J. 2004. PMID: 15289448

8

The anandamide membrane transporter. Structure-activity relationships of anandamide and oleoylethanolamine analogs with phenyl rings in the polar head group region.

Di Marzo V, Ligresti A, Morera E, Nalli M, Ortar G. Di Marzo V, et al. Among authors: ligresti a. Bioorg Med Chem. 2004 Oct 1;12(19):5161-9. doi: 10.1016/j.bmc.2004.07.026. Bioorg Med Chem. 2004. PMID: 15351399

9

The endocannabinoid signalling system: biochemical aspects.

Bisogno T, Ligresti A, Di Marzo V. Bisogno T, et al. Among authors: ligresti a. Pharmacol Biochem Behav. 2005 Jun;81(2):224-38. doi: 10.1016/j.pbb.2005.01.027. Pharmacol Biochem Behav. 2005. PMID: 15935454 Review.

10

Endocannabinoid metabolic pathways and enzymes.

Ligresti A, Cascio MG, Di Marzo V. Ligresti A, et al. Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):615-23. doi: 10.2174/156800705774933104. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16375679 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters